Familial gastric cancer: genetic susceptibility, pathology, and implications for management.

Keywords

Medicine, Cancer, Familial adenomatous polyposis, CDH1, Cancer syndrome

References

• Convex Total Variation Denoising of Poisson Fluorescence Confocal Images With Anisotropic FilteringMariano Madurga Sanz — 2011
• E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.Carla Oliveíra, Hugo Pinheiro, Joana Figueiredo — 2013
• BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.Bernard Friedenson — 2005
• Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancerWilliam M. Grady, Joseph Willis, Parry Guilford — 2000
• E-cadherin germline mutations in familial gastric cancerParry Guilford, Justin Hopkins, James Harraway — 1998
• Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndromeValeria Molinaro, Valeria Pensotti, Monica Marabelli — 2014
• Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.Simon A. Gayther, Kylie L. Gorringe, Susan J. Ramus — 1998
• Pregnancy after prophylactic total gastrectomyPardeep Kaurah, Rebecca C. Fitzgerald, S Dwerryhouse — 2010
• Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at riskM. D. Barber, Vicki Save, Fátima Carneiro — 2008
• Therapeutic targets associated to E-cadherin dysfunction in gastric cancerPatrı́cia Carneiro, Joana Figueiredo, Renata Bordeira–Carriço — 2013
• Germline Mutations in MAP3K6 Are Associated with Familial Gastric CancerDaniel Gaston, Samantha Hansford, Carla Oliveíra — 2014
• Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1): Pathologic Findings With Clinical ImplicationsWilliam M. Rogers, Erika Dobo, Jeffrey A. Norton — 2008
• A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancerAnna Jakubowska, Rodney J. Scott, Janusz Menkiszak — 2003
• Loss of E‐cadherin in mouse gastric epithelial cells induces signet ring‐like cells, a possible precursor lesion of diffuse gastric cancerAyako Mimata, Hiroshi Fukamachi, Yoshinobu Eishi — 2011
• Gastric cancer: New genetic developmentsHenry T. Lynch, William M. Grady, Gianpaolo Suriano — 2005
• Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cellsHyun Chang, Sun Young Rha, Hei‐Cheul Jeung — 2010
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.David Malkin, Frederick P. Li, Louise C. Strong — 1990
• E‐cadherin dysfunction in gastric cancer ‐ Cellular consequences, clinical applications and open questionsPatrı́cia Carneiro, Maria Sofia Fernandes, Joana Figueiredo — 2012
• Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.Bostjan Humar, Ryuji Fukuzawa, Vanessa Blair — 2007
• Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012Nils Rahner, Verena Steinke, Brigitte Schlegelberger — 2012

Cited by

• Current Perspectives on Gastric CancerLourdes Eugenia Osorio Bayter, Darío Quiroga Parra, Darío Espinosa Correa — 2016
• Current perspectives toward the identification of key players in gastric cancer microRNA dysregulationTakatsugu Ishimoto, Hideo A. Baba, Daisuke Izumi — 2016
• Hereditary Gastric Cancer Syndromes.Hugh Shunsuke Colvin, Ken Yamamoto, Noriko Wada — 2015
• Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?Bar Chikman, Tima Davidson, Hasan Kais — 2015
• Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.Patrick Tan, Khay Guan Yeoh — 2015
• Emerging blood-based biomarkers for detection of gastric cancer.Zane Kalniņa — 2015
• Pathogenesis of Gastric CancerCéu Figueiredo, Susana Costa, Andreas Karameris — 2015
• Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutationPatrick R. Benusiglio, C. Colas, Etienne Rouleau — 2015
• MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and SnailQ-F Zuo, L-Y Cao, Ting Yu — 2015
• Hereditary gastrointestinal cancerKeisuke Hata, Yoko Yamamoto, Tomomichi Kiyomatsu — 2016
• Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologiesMasakazu Kohda, Kensuke Kumamoto, Hidetaka Eguchi — 2016
• Clinical impact of tumour biology in the management of gastroesophageal cancerFlorian Lordick, Yelena Y. Janjigian — 2016
• Lauren classification and individualized chemotherapy in gastric cancerJunli Ma, Hong Shen, Linda Kapesa — 2016
• Clinicopathologic Features and Germline Sequence Variants in Young Patients (⩽40 Years Old) With Pancreatic Ductal AdenocarcinomaAkihiro Ohmoto, Shinichi Yachida, Emi Kubo — 2016
• Quantification of topological features in cell meshes to explore E-cadherin dysfunctionTânia Mestre, Joana Figueiredo, Ana Sofia Ribeiro — 2016
• Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.Byungho Lim — 2016
• Challenges of deciphering gastric cancer heterogeneity.Petra Hudler — 2015
• The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature.Rudolf Repák, Darina Kohoutová, Miroslav Podhola — 2016
• Effect of World Health Organization (WHO) Histological Classification on Predicting Lymph Node Metastasis and Recurrence in Early Gastric CancerJi Fu Lai, Wen Na Xu, Sung Hoon Noh — 2016
• Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.Rachel S. van der Post, Irene Gullo, Carla Oliveíra — 2016

Related papers

• The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutationsAmanda G Silva, Ana Cristina Victorino Krepischi, P. Pearson — 2014
• [Description of a new TP53 gene germline mutation in a family with the Li-Fraumeni syndrome. Genetic counselling to healthy mutation carriers].Judith Balmañà, Josep Nomdedéu, Orland Dı́ez — 2002
• Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defectAndreas Schwarz — 2003
• Prevalence and penetrance of Li-Fraumeni cancer predisposition syndromeChang S. Chan — 2017
• Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.Vera Krutilkova, Marie Trková, Julie Fleitz — 2005
• Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.Michael D. Black, Raynette Kaneshiro, Jennifer I. Lai — 2014
• Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients.Ken Yamaguchi, Kenichi Urakami, Takeshi Nagashima — 2016